Sundar.M
☆    

India,
2019-02-15 13:37

Posting: # 19925
Views: 765
 

 Dose curve [PK / PD]

Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN
Activity
 Admin contact
20,793 posts in 4,353 threads, 1,445 registered users;
online 12 (0 registered, 12 guests [including 6 identified bots]).
Forum time: 21:27 CEST (Europe/Vienna)

In God we trust;
all others must bring data.    W. Edwards Deming

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5